Toxicity Studies of Oxy Powder®-Revised

Authors

  • JOGENDER K. LALLA 1Mayfair Clinical Education and Research Centre, the Coordinating Research Centre, Sanskruti.20/701, 90 Feet Road, Thakur Complex, Kandivli (E),Mumbai- 400 101 (INDIA),
  • MEENA U.SHAH 2CEO, GLOBAL HEALING CENTER INC. (GHC) the Project Sponsor, 2040 North Loop West, Suite 108 Houston, Texas 77018, (USA)
  • EDWARD F III GROUP 2CEO, GLOBAL HEALING CENTER INC. (GHC) the Project Sponsor, 2040 North Loop West, Suite 108 Houston, Texas 77018, (USA)

Keywords:

GHC’s Oxy Powder®, Dietary supplement – In vitro Toxicity to Microbes – Acute oral (LD50) Toxicity in Sprague Dawley Rats.

Abstract

The objective of this study was to assess the toxic effects of Oxy powder® in-vitro on four pathogenic microbes and a probiotic bacterium generally present in the human GI tract and to determine acute oral toxicity (LD50) profile of Oxy Powder® in Sprague Dawley rats. The results shall be used in selecting doses in repeated dose toxicity study of Oxy Powder. 

Downloads

Published

30.06.2010

How to Cite

JOGENDER K. LALLA, MEENA U.SHAH, & EDWARD F III GROUP. (2010). Toxicity Studies of Oxy Powder®-Revised. International Journal of Pharma and Bio Sciences, 1(2), 1–14. Retrieved from https://ijpbs.net/index.php/journal/article/view/42

Issue

Volume 1, Issue 2, 2010

Section

Research Articles